home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Acceleron Pharma

SHARESHARESHARE
Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to treat serious and rare diseases.
SHARESHARESHARE

RELATED NEWS


Merck and Pfizer faced uncertainty on big-selling vaccines going into this week meeting of the Advisory Committee on Immunization Practices, a CDC panel that sets U.S. vaccination policy. But in votes on Wednesday, the panel either maintained favourable recommendations for the vaccines, or in Merck’s case, expanded recommendations. ACIP expanded its recommendation for Merck’s HPV vaccine Gardasil 9 to men and women aged 27 through 45 who aren’t adequately vaccinated. The panel ...

READ MORE

A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer's disease even before they show signs of confusion and memory loss, according to a new study from Washington University School of Medicine in St. Louis and the German Center for Neurodegenerative Diseases in Germany. The findings published Jan. 21 in Nature Medicine, may one day be applied to quickly and inexpensively identify brain damage in people with not just Alzheimer's disease b...

READ MORE

Formerly the company’s chief finance officer, Hubertus von Baumbach has been in post since last June when he took over from Andreas Barner, and is overseeing strong growth....

READ MORE

Impel NeuroPharma, a Seattle-based, privately-held biotechnology company focused on therapies for the treatment of CNS disorders, announced positive results from a recently completed phase 1 proof-of-concept trial of INP104 for acute migraine headache. INP104 is a novel dihydroergotamine (DHE) product dosed via Impel's proprietary Precision Olfactory Delivery, or POD, intranasal delivery device.

This proof-of-concept trial, INP104-101, demonstrated statistically significant im...

PHARMACEUTICAL EXECUTIVE
READ MORE

New research challenges established medical practice that all heart attack patients should be on beta blockers. The study - by a research team at the University of Leeds - looked at patients who had a heart attack but did not suffer heart failure - a complication of a heart attack where the heart muscle is damaged and ceases to function properly....

READ MORE

ICRA expects growth trajectory for Indian pharmaceutical industry to moderate on back of slowing growth from US, increased competition, and regulatory overhang along with base effect catching up....

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...